Published Dec 10, 2021

Labshares Newton Doubles Space for Emerging Biotech Startups

Labshares News
Copy The Link to the  Article
Labshares Newton Doubles Space for Emerging Biotech Startups
Copy The Link to the  Article

Related or similar articles

View more News
August 8, 2018

Harbour BioMed inks $350 million deal for rights to A167

USA-based Harbour BioMed has entered into an exclusive strategic partnership with China’s Sichuan Kelun-Biotech Biopharmaceutical to develop and commercialize A167
Member News
July 16, 2025

A Different Take on Boston’s Biotech Future

Why does Boston remain a global biotech leader? Its research institutions, funding network, and flexible shared lab infrastructure help emerging life science companies to conserve capital and grow.
Blog Posts
September 17, 2026

Biotech's Cathedral Problem: Rethinking the Path From Incubator to Lease

Blog Posts